BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 23929259)

  • 1. Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy.
    Jaiman S; Sharma AK; Singh K; Khanna D
    Eur J Clin Pharmacol; 2013 Nov; 69(11):1863-74. PubMed ID: 23929259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathy.
    Guerrero-Beltrán CE; Mukhopadhyay P; Horváth B; Rajesh M; Tapia E; García-Torres I; Pedraza-Chaverri J; Pacher P
    J Nutr Biochem; 2012 May; 23(5):494-500. PubMed ID: 21684138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementation of American ginseng berry extract mitigated cisplatin-evoked nephrotoxicity by suppressing ROS-mediated activation of MAPK and NF-κB signaling pathways.
    Ma ZN; Liu Z; Wang Z; Ren S; Tang S; Wang YP; Xiao SY; Chen C; Li W
    Food Chem Toxicol; 2017 Dec; 110():62-73. PubMed ID: 29024717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.
    Pabla N; Dong G; Jiang M; Huang S; Kumar MV; Messing RO; Dong Z
    J Clin Invest; 2011 Jul; 121(7):2709-22. PubMed ID: 21633170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-κB signalling pathways.
    Ma X; Dang C; Kang H; Dai Z; Lin S; Guan H; Liu X; Wang X; Hui W
    Int Immunopharmacol; 2015 Sep; 28(1):399-408. PubMed ID: 26118633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalein, a Bioflavonoid, Prevents Cisplatin-Induced Acute Kidney Injury by Up-Regulating Antioxidant Defenses and Down-Regulating the MAPKs and NF-κB Pathways.
    Sahu BD; Mahesh Kumar J; Sistla R
    PLoS One; 2015; 10(7):e0134139. PubMed ID: 26222683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
    Pabla N; Huang S; Mi QS; Daniel R; Dong Z
    J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.
    Benedetti G; Fredriksson L; Herpers B; Meerman J; van de Water B; de Graauw M
    Biochem Pharmacol; 2013 Jan; 85(2):274-86. PubMed ID: 23103562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-apoptotic functions of TRAF2 in p53-mediated apoptosis induced by cisplatin.
    Tsuchida M; Yokosawa T; Noguchi T; Shimada T; Yamada M; Sekiguchi Y; Hirata Y; Matsuzawa A
    J Toxicol Sci; 2020; 45(4):219-226. PubMed ID: 32238696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance.
    Brozovic A; Osmak M
    Cancer Lett; 2007 Jun; 251(1):1-16. PubMed ID: 17125914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
    Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stanniocalcin-1 Protects a Mouse Model from Renal Ischemia-Reperfusion Injury by Affecting ROS-Mediated Multiple Signaling Pathways.
    Liu D; Shang H; Liu Y
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of both tumor necrosis factor-alpha-induced necrosis and p53-mediated caspase-dependent apoptosis in nephrotoxicity of cisplatin.
    Yano T; Itoh Y; Matsuo M; Kawashiri T; Egashira N; Oishi R
    Apoptosis; 2007 Oct; 12(10):1901-9. PubMed ID: 17701360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line.
    Hayakawa J; Ohmichi M; Kurachi H; Ikegami H; Kimura A; Matsuoka T; Jikihara H; Mercola D; Murata Y
    J Biol Chem; 1999 Oct; 274(44):31648-54. PubMed ID: 10531373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of platinum accumulation, inflammation and apoptosis in the kidney.
    Domitrović R; Cvijanović O; Pugel EP; Zagorac GB; Mahmutefendić H; Škoda M
    Toxicology; 2013 Aug; 310():115-23. PubMed ID: 23770416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mst1 deletion attenuates renal ischaemia-reperfusion injury: The role of microtubule cytoskeleton dynamics, mitochondrial fission and the GSK3β-p53 signalling pathway.
    Li H; Feng J; Zhang Y; Feng J; Wang Q; Zhao S; Meng P; Li J
    Redox Biol; 2019 Jan; 20():261-274. PubMed ID: 30384260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan ameliorates cisplatin-induced nephrotoxicity by inhibiting MAPK mediated inflammation and apoptosis.
    Malik S; Suchal K; Gamad N; Dinda AK; Arya DS; Bhatia J
    Eur J Pharmacol; 2015 Feb; 748():54-60. PubMed ID: 25510231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genipin attenuates cisplatin-induced nephrotoxicity by counteracting oxidative stress, inflammation, and apoptosis.
    Mahgoub E; Kumaraswamy SM; Kader KH; Venkataraman B; Ojha S; Adeghate E; Rajesh M
    Biomed Pharmacother; 2017 Sep; 93():1083-1097. PubMed ID: 28738532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity.
    Song Z; Zhu J; Wei Q; Dong G; Dong Z
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F1041-F1052. PubMed ID: 32150448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinalizarin exerts an anti-tumour effect on lung cancer A549 cells by modulating the Akt, MAPK, STAT3 and p53 signalling pathways.
    Meng LQ; Liu C; Luo YH; Piao XJ; Wang Y; Zhang Y; Wang JR; Wang H; Xu WT; Liu Y; Wu YQ; Sun HN; Han YH; Jin MH; Shen GN; Zang YQ; Li J; Fang NZ; Cui YD; Jin CH
    Mol Med Rep; 2018 Feb; 17(2):2626-2634. PubMed ID: 29207064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.